Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 13.94m |
Free float | 13.85m |
P/E (TTM) | -- |
Market cap | 4.99m USD |
EPS (TTM) | -3.87 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
- Aethlon Medical to Present at Virtual Investor Conferences in September
- Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
- Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
- Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update
- Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial
- Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024
- Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
More ▼